Haɓaka aikace-aikacen ƙananan ƙwayoyin cuta na masana'antu a cikin magunguna da masana'antar abinci & abin sha a duk faɗin China, Amurka, Jamus da Indiya za su haɓaka buƙatun ƙwayoyin cuta na masana'antu a duk duniya.
Haɓaka ɗaukar haifuwa da gwajin nauyin halitta a cikin masana'antar harhada magunguna zai haɓaka siyar da samfuran ƙwayoyin cuta na masana'antu.
Haɓaka ayyukan bincike da haɓakawa tare da haɓaka haɓakar magunguna a cikin masana'antar biopharmaceutical a duk faɗin Amurka, Faransa, da Indiya zai haɓaka haɓakar kasuwa a cikin shekaru goma masu zuwa.
Haɓaka aikace-aikace a cikin abubuwan da ake amfani da su na magunguna sun ƙarfafa ɗaukar nauyin haifuwa da gwajin ƙwayoyin halitta don ingancin gwajin magunguna da ƙananan ƙwayoyin cuta. Koyaya, ƙarancin ƙwararrun ƙwararrun ma'aikata da samar da tsada mai tsada na iya kawo cikas ga haɓakar ƙananan ƙwayoyin cuta na masana'antu.
Sakamakon barkewar COVID-19 wanda ba a taɓa ganin irinsa ba, tallace-tallacen microbiology na masana'antu ya ƙi ta 1.95%, yana nuna CAGR a 4.95% a lokacin kintace.
Koyaya, tare da haɓaka yunƙurin rage gurɓataccen gurɓataccen gurɓataccen ruwa da haɓaka ingantaccen maganin ruwa, ƙimar kasuwar microbiology na masana'antu za ta kai. US $ 21,566.24 Mn ta 2031.
Don ci gaba da gaban masu fafatawa, nemi samfurin - https://www.futuremarketinsights.com/reports/sample/rep-gb-1743
Mahimman abubuwan da za a ɗauka daga Nazarin Kasuwar Microbiology na Masana'antu ta FMI
- Ana sa ran masana'antar harhada magunguna za ta zama farkon mai amfani da kasuwar microbiology na masana'antu
- Gwajin rashin haihuwa shine nau'in gwajin da aka fi so a tsakanin manyan 'yan wasan da ke goyan bayan karuwar aikace-aikacen a masana'antar harhada magunguna
- Ana sa ran haɓaka aikace-aikacen microbiology na masana'antu a cikin abinci & abin sha zai haɓaka tallace-tallace, musamman a duk Amurka da Indiya.
- Dangane da samfur, ana sa ran abubuwan da ake amfani da su na amsawa zasu jagoranci sashin sama da lokacin hasashen
- Ana tsammanin Indiya za ta fito a matsayin kasuwa mai riba saboda haɓaka masana'antar kiwon lafiya da haɓaka aikace-aikace a cikin masana'antar harhada magunguna
- Ana sa ran Jamus za ta kasance ƙasa mafi samun riba, wanda zai ƙare 31% na kasuwar duniya
- Ana sa ran kasar Sin za ta jagoranci kasuwannin gabashin Asiya a lokacin hasashen, tare da yin rijistar babban ci gaba a lokacin tantancewar.
- An kiyasta Amurka ita ce babbar kasuwa don kasuwar microbiology na masana'antu wanda aka danganta da karuwar buƙatun masu amfani da haɓakar karɓar gwajin haifuwa a cikin masana'antar harhada magunguna.
"Maɓallai 'yan wasa suna haɓaka ayyukan bincike & haɓaka don sauƙaƙe gano magunguna da gwajin abinci a cikin masana'antar harhada magunguna & abinci. Wannan, bi da bi, yana yiwuwa ya faɗaɗa damammakin ci gaba ga ƴan kasuwa a cikin shekaru masu zuwa, "in ji manazarcin FMI.
Gasar Gasar Gasar
Hasashen Kasuwa na gaba, a cikin rahotonsa da aka sabunta, ya ba da bayyani ga fitattun 'yan wasa da ke aiki a kasuwar microbiology na masana'antu waɗanda suka haɗa da
- Thermo Fisher Kimiyyar Kimiyya Inc.
- Bio-Rad dakunan gwaje-gwaje Inc.
- Ruwan sama
- Dickinson da Kamfanin
- Asiagel Corporation girma
- Eppendorf AG girma
- bioMérieux SA girma
- Novamed.
- QIAGEN
- Sartorius AG girma
- 3M
- Merck KGaA da Danaher Corporation da sauransu.
Masu kera tsarin microbiology na masana'antu suna mai da hankali sosai kan faɗaɗa tarin samfuran su don haɓaka samar da kudaden shiga.
Dangane da FMI, manyan ƴan wasa sun mamaye kasuwa kamar Thermo Fisher Scientific Inc. da BioMerieuxx Inc. wanda ke sa kasuwar ta haɗe.
Haɗin kai da aka yi niyya da haɗin gwiwa tare da manyan kamfanonin kiwon lafiya da kamfanonin harhada magunguna ana tsammanin su zama mahimmin dabarun kula da babban matsayi a cikin masana'antar.
Sabbin samfura da aka ƙaddamar tare da faɗaɗa kewayon samfuran su na ɗaya daga cikin dabarun kasuwa gama gari don manyan ƴan wasa. Misali:
A cikin Maris 2020, babban ɗan wasa, Danaher Corporation ya ba da sanarwar siyan kasuwancin biopharma daga Sashen Kimiyyar Rayuwa na Janar Electronics. Tare da wannan siyan, an canza sunan kamfanin zuwa Cytiva kuma zai yi aiki a matsayin kamfani mai zaman kansa a cikin Kamfanin Danaher.
Karin Hazaka kan Kasuwar Masana'antu ta Duniya
Hasashen Kasuwa na gaba, a cikin sabon rahotonsa, yana ba da cikakken ɗaukar hoto kan kasuwar microbiology na masana'antu ta duniya, yana ba da bayanan tarihi na tsawon lokacin 2016-2020 da kididdigar hasashen lokacin 2021-2031. Don fahimtar yuwuwar kasuwancin duniya, haɓakarta, da iyakokinta, ana rarraba kasuwa akan nau'in samfur (kayan aiki da tsarin, abubuwan da ake buƙata, da sauransu), nau'in gwaji (gwajin haihuwa, gwajin iyakokin ƙwayoyin cuta, da bio- gwajin nauyi), kuma mai amfani na ƙarshe (magunguna & ilimin halittu, abinci & abubuwan sha, noma & muhalli, da samfuran kulawa) a cikin manyan yankuna bakwai (Arewacin Amurka, Latin Amurka, Gabashin Turai, Asiya Pacific ban da Japan, Yammacin Turai, Japan da Tsakiyar Tsakiya Gabas & Afirka)
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- In order to understand the global market potential, its growth, and scope, the market is classified on the basis of product type (equipment and systems, reaction consumables, and others), test type (sterility testing, microbial limits testing, and bio-burden testing), and end user (pharmaceutical &.
- is estimated to be the largest market for industrial microbiology market attributed to the growing consumers demand and surge in adoption of sterility testing in pharmaceutical industry.
- Future Market Insights, in its latest report, offers an incisive coverage on the global industrial microbiology market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031.
